Lu Jiang

机构：Shanghai Jiao Tong University, Tianjin First Center Hospital, Ruijin Hospital, Tianjin Medical University · ORCID：0000-0001-8623-477X

发表论文 21 篇 · 总被引 250 次 · h-index 7

代表论文

• Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial (2019 · The Lancet Haematology · 被引 50)
• Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study (2022 · The Lancet Healthy Longevity · 被引 36)
• Exome Sequencing Identifies Somatic Mutations of DDX3X in Natural Killer/T-Cell Lymphoma (2014 · Blood · 被引 35)
• Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy (2023 · Frontiers of Medicine · 被引 29)
• Pharmacological mechanism of Shenlingbaizhu formula against experimental colitis (2022 · Phytomedicine · 被引 29)
• The pharmacological validation of the Xiao-Jian-Zhong formula against ulcerative colitis by network pharmacology integrated with metabolomics (2022 · Journal of Ethnopharmacology · 被引 20)